A detailed history of Kestra Advisory Services, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 15,419 shares of VXRT stock, worth $10,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,419
Previous 15,419 -0.0%
Holding current value
$10,330
Previous $8,000 150.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.57 - $0.85 $1,424 - $2,125
2,500 Added 19.35%
15,419 $8,000
Q3 2023

Nov 09, 2023

SELL
$0.69 - $0.85 $0 - $0
-1 Reduced 0.01%
12,919 $9,000
Q2 2023

Aug 11, 2023

BUY
$0.6 - $1.41 $1,200 - $2,820
2,000 Added 18.32%
12,920 $9,000
Q1 2023

May 12, 2023

SELL
$0.71 - $1.25 $9,145 - $16,101
-12,881 Reduced 54.12%
10,920 $8,000
Q4 2022

Jan 31, 2023

BUY
$0.75 - $2.24 $1,848 - $5,521
2,465 Added 11.55%
23,801 $22,000
Q3 2022

Nov 01, 2022

BUY
$2.09 - $4.5 $44,592 - $96,012
21,336 New
21,336 $47 Million

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $84.8M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.